Experiments in Mice May Help Boost Newly FDA-Approved Therapy for Spinal Muscular Atrophy
Monday, January 9, 2017 - 09:01
in Biology & Nature
Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy.